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To evaluate the health consequences for children of indoor exposure to molds, an international
workshop was organized with 15 scientists from eight countries. The participants agreed that
exposure to molds may constitute a health threat to children resulting in respiratory symptoms in
both the upper and lower airways, an increased incidence of infections, and skin symptoms.
Allergy, either to molds or to other indoor agents, also presents a health risk. At very high exposure
levels to specific molds, nose bleeding, hemoptysis, and pulmonary hemorrhage have been
documented. Pediatricians and allergists need to obtain information about mold and dampness in
the home environment when examining children with chronic respiratory symptoms, recurrent
infections, or persistent fatigue and headache. Measurement techniques are available to
determine exposure. Most important, the source of dampness must be eliminated and the indoor
environment must be thoroughly cleaned of molds. Key words: asthma, inflammation, molds,
prevention, sampling. - Environ Health Perspect 107(suppl 3):465-468 (1999).
http.//ehpnetl.niehs.nih.gov/docs/1999/suppl-3/465-468rylander/abstract.html
Background
Reactive airways disease in children is
increasing in many countries. The clinical
diagnosis ofasthma or reactive airways dis-
ease includes a variable airflow obstruction
and an increased airway responsiveness.
This condition can develop after an aug-
mented reaction to a specific agent (aller-
gen) and may cause a life-threatening
situation within a very short period of
exposure. It can also develop after long-
term exposure to irritating agents that
cause inflammation in the airways in the
absence of an allergen.
Several environmental agents are
associated with exacerbations ofchildhood
asthma. They include mite allergens, cat
dander, outdoor and indoor air pollution,
cooking fumes, and infections. There is,
however, increasing evidence that mold
growth indoors in damp buildings is an
important risk factor for childhood respira-
tory illness. About 40 investigations from
many different countries have demonstrated
an association between living in damp
homes or homes with mold growth, and
adverse respiratory symptoms in children.
Some studies show a relation between
dampness/mold and objective measures of
lung function or a history of respiratory
infections. Apart from respiratory symptoms,
some studies demonstrate the presence of
general symptoms in terms of fatigue,
headache, and symptoms from the central
nervous system. At excessive exposures to
certain toxigenic molds, an increased risk for
pulmonary hemorrhage and death among
infants has been documented.
The described effects may have impor-
tant consequences for children in the early
years of life. A child's immune system
develops from birth to adolescence and
requires a natural stimulation with antigens
as well as inflammatory agents. Any distur-
bances of this normal maturing process
may increase the risk for abnormal reac-
tions to inhaled antigens and irritants in
the environment.
Knowledge about health risks due to
mold exposure is not widespread among
clinicians, and public health authorities in
some countries may not be aware of the
serious reactions mold exposure can pro-
voke in some children. Individual physi-
cians may have difficulties treating these
children because ofthe lack ofrecognition
of the relationship between the symptoms
and the indoor environment.
This workshop was organized to
develop a basis for risk assessment and for-
mulation ofrecommendations, particularly
for diagnostic purposes. The participants
were all active researchers with current
experience in child health, molds, and res-
piratory disease. During the workshop,
three work groups were formed, given spe-
cific problems and questions regarding the
different aspects of the relationship
between molds and children's health, and
asked to produce a written report. These
reports were discussed in a plenary session
and further revised and circulated several
times to all participants.
Conclusions and
Recommendations
oftheWorkshop
Symptoms andPathology
Children in homes with dampness and/or
mold growth are at higher risk for episodic
and/or persistent upper respiratory symp-
toms such as rhinitis, blocked nose, sneez-
ing, eye irritation, and hoarseness, as well as
lower respiratory tract symptoms such as dry
or productive cough and wheezing (1-3).
They may also have skin symptoms-itch-
ing and redness-that can be present both
in exposed areas of the body (suggesting
contact dermatitis) or in areas protected by
clothing (suggesting other mechanisms).
Systemic symptoms such as headache,
fever, excessive fatigue, and joint pains
have been described among persons in
moldy environments but are less well docu-
mented, and the underlying mechanisms
are not known. Food intolerance to mold
in cheese, wine, beer, and mushrooms has
also been described (4). Unusual symp-
toms reported in high-exposure conditions,
and particularly in connection with the
exposure of infants to certain toxigenic
fungi (e.g., Stachybotrys), are nosebleeding
and hemoptysis (5,6).
It is very important that when a physi-
cian evaluates a child with these symp-
toms, specific questions about the home,
child care setting, or school environments
are asked.
The pathologic mechanisms for the
respiratory symptoms can be considered
to result from inflammation (7). This
inflammation can be induced by the well-
recognized allergic, IgE-mediated mecha-
nisms but also by nonallergic mechanisms
induced by toxic agents, where macrophages
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and lymphocytes play important roles.
Molds contain agents able to induce all these
reactions: a number ofwell-defined aller-
gens, immunomodulating agents such as
(1- 3)-P-D-glucan, and mycotoxins.
Although children with diagnosed or
suspected IgE-related airway inflammation
dominate the clientele at outpatient
departments for pediatric lung disease or
allergy, data from epidemiologic studies
suggest that nonspecific inflammation may
be the most common pathology among a
larger group of children not selected for
hospital admission.
The inflammatory response in chil-
dren's airways can be both augmented and
suppressed by simultaneous exposure to
environmental agents. These considerations
are separate from the infection concerns in
immune-suppressed children. In view ofthe
profound changes in the immune system
during its development in infancy and early
childhood, such environmental exposures
are likely to be ofimportance by inducing
hypersensitivity or modifying the immuno-
logic maturation process, steering away
from the allergic Th2-driven response at
birth to a Thl-driven response (8).
Pathologic reaction patterns induced by
environmental exposure can manifest
themselves throughout the remainder of
childhood and adolescence as impacted
by puberty.
All responses to the environment, in
terms ofboth allergy and inflammation, are
related to the genetic predisposition ofthe
individual, particularly those with an atopic
predisposition. The influences ofgender and
race on riskare notyetfullyunderstood.
Children with symptoms related to
mold in houses may also be more suscepti-
ble to inhaled agents in general such as
particulates, smoke, and chemicals. The
presence of such increased airway symp-
toms should be regarded as a further indi-
cation to pose questions about the housing
environment in which the child lives.
DiagnosticMethods
For the clinician faced with a child with
symptoms possibly related to exposure to
indoor air, the initial aim is to rule out
other diseases such as bronchiectasis and
congenital immune deficiencies.
Diagnostic tools must be used in a
focused and stepwise manner, depending
on the severity ofthe symptoms, and their
potential relationship to the indoor envi-
ronment. A child may be exposed in vari-
ous environments simultaneously, e.g.,
in the home, child care setting or school
environment, and during play activities,
which makes the evaluation of possible
risk factors and temporal relationships
quite complicated.
A history of an environment-related
symptomatology is very important (i.e.,
child has symptoms in home/school/child
care setting and does not have symptoms
elsewhere). When the symptoms are sus-
pected to have an allergic etiology, a blood
eosinophil count, total IgE concentration,
and skin prick tests (SPTs) should be con-
sidered. SPTs have useful predictive value
when testing with standardized allergen
extracts for allergy to pets, dust mites, and
pollen (9,10). Fungal SPT extracts may be
unreliable, often because of lack of stan-
dardization ofthe extracts. In addition, the
panel offungal allergen extracts available to
the clinician does not accurately reflect the
true mold exposure profile in most indoor
enviroments. A negative SPT can, on the
other hand, reflect the presence of a non-
specific inflammation. There are no pub-
lished data comparing microbial-specific
(radioallergosorbent tests [RAST]) tests
and respective SPT results. Approximately
15 microbes account for the vast majority
ofpositive findings.
Determination of mold-specific
IgE antibodies (RAST, enzyme-linked
immunosorbent assay [ELISA]) is also a
useful method to identify specific IgE-
mediated response, but high costs limit the
use of this test in primary health care.
RAST and related tests have lower sensitiv-
ity than SPTs. The finding ofa high total
IgE level supports a relation between expo-
sure and allergic symptoms. Ifspecific IgE
levels are low, one may be dealing with a
nonallergic inflammatory pathogenesis for
the symptoms.
Further diagnostic analyses depend on
the symptom complex. For example, with
persistent lower respiratory tract symptoms,
measures of reversible airflow obstruction
and airway responsiveness should be made
(11). Peak expiratory flow, flow volume,
and spirometry may be used, depending on
the age of the patient. The diagnosis of
asthma in an infant is a clinical diagnosis
based on a judgment of an experienced
clinician, in most cases apediatrician.
Only a few tests of nonallergic inflam-
mation are currently available and they are
used mainly in research. Some of these
tests provide promising results and may
provide additional information on the
pathophysiologic mechanisms behind the
symptoms associated with exposure to
microorganisms. Determinations of
inflammatory cytokines in nasal lavage
fluid or induced sputum or nitric oxide
concentrations in exhaled air are examples
ofsuch tests.
Ifhypersensitivity pneumonitis (allergic
alveolitis), toxic pneumonitis (organic dust
toxic syndrome), or pulmonary hemor-
rhage is suspected, leukocyte counts and
neutrophil/lymphocyte ratios should be
determined. More extensive tests are avail-
able such as measurements of total lung
capacity and diffusion capacity and bron-
choscopy with alveolar lavage, but they are
to be used only in clinically severe cases or
in those with diagnostic doubt. If pul-
monary hemorrhage is suspected, hemo-
siderin-laden macrophages should be
counted. Additionally, particularly in
infants, possible anemia should be assessed
and stools checked for occult blood (12).
In toxic pneumonitis, no diagnostic tools
need to be used as the disease disappears
within 24 hr.
Microbe-specific IgG antibodies (pre-
cipitins, IgG, ELISA antibodies) can be
determined but are useful only as markers
ofthe exposure.
MeasurementTools forUse in
EpidemiologicStudies
Questionnaires are the golden standard and
are available for all age groups including
children. The questionnaires should be vali-
dated and tested for sensitivity and speci-
ficity. Symptom diaries are easy to use if
children are well motivated and older than
about 10 years of age. Alternatively, the
parents can complete the diaries, although
their information may not be as accurate.
Symptom diaries, together with peak flow
measurements, give more precise and objec-
tive information on the spatial and tempo-
ral relationship between suspected exposure
and symptoms. Spirometry before and after
physical exercise among children, SPT,
RAST, specific IgE, and the previously
mentioned cell-related tests may be useful,
but a control group of children with no
indoor-related symptoms must always
be included.
Environmental Measurements
Assessment of the condition of the build-
ing and measurements of the presence of
molds are important activities in the
process ofrelating a child's symptoms and
clinical findings with mold exposure.
Questions on the presence of molds at
home or in the school/child care setting
can be posed in a clinical examination or in
a questionnaire (13). Important questions
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to be included in such investigations are
the following:
* Do you notice a moldy/earthy or cellar-
like odor in the home/child care set-
ting/school?
* Is there a history ofwater damage such
as leakage from water pipes or washing
machines, boiler, refrigerator, freezer,
or cooling of the ventilation system in
the child's home/child care setting/
school?
* Do you have, or have you previously
had, visible signs of moisture damage
such as damp stains or spots, deteriora-
tion or darkening ofsurface materials
in the ceiling, walls, or floors, or signs
ofcondensation ofwater on surfaces in
the home/child care setting/school?
* Do your child's symptoms change or
disappear when she/he is away from the
home/child care setting/school?
* Is there anything in particular that
aggravates your child's symptoms?
In addition, questions on the ventilation
system could give important information:
What kind ofheating system/ventilation
system do you have? Do you have air condi-
tioning? How often are air cleaners in use?
How often are air filters changed or
cleaned? Are special filters such as electric
precipitators used? These questions mayvary
or be left out according to local practices
in different climatic conditions.
Important information for the diagnosis
can also be obtained by paying a visit to
the child's home, school, or child care set-
ting. Observations ofmoisture spots, water
leakage, mold spots, or mold or earthy
odor support the hypothesis of a mold
exposure. On wallboards, mold growth suf-
ficient to influence the air quality extends
as much as 0.5-1 m beyond visible mold
cultures. There may also be hidden damage
and mold growth behind the surface mate-
rials such as wallpaper, gypsum board, or
carpets, which can affect indoor air quality.
The decision to remediate a structure
can often be made by visual inspection and
without sampling microorganisms. Ifwater
intrusion has occurred, timely action is
essential because mold growth can prolifer-
ate extensively within a few days. The first
step must be to eliminate the source of
water. Ifvisible mold growth is extensive,
air and bulk samples for molds should be
taken prior to remedial action to identify
the organisms. Sampling in the absence of
visible mold growth may also be merited to
assure that there are no further hidden
sources ofmold. A difference in rank order
of mold species inside when compared to
outside is the gold standard for diagnosing
building contamination. Identification of
mold species is important because some are
known to produce potent mycotoxins, e.g.,
tricothecenes by Stachybotrys chartarum
(13,14). Extensive mold growth, especially
toxigenic mold growth, also requires that
the remedialworkers be protected (14,15).
Accurate exposure assessment is difficult
with currently available sampling and analy-
sis methods. No single measurement tech-
nique is entirely suitable, and sampling
should never be conducted alone but in
conjunction with inspection. A measure of
culturable molds (as colony-forming units)
in an air sample is oflittle value because the
sampling periods oftraditional methods are
too short to represent accurately the vari-
abilityofconcentrations over time. Also, the
culturable portion represents only a small
fraction ofthe total number ofmold spores
present in an air, dust, or bulksample.
The analysis ofsettled dust can provide
a time-integrated index ofexposure. In set-
tled dust samples, measures of total cell
mass using ergosterol or(1-*3)-P-D-glucan,
and cytotoxicity tests have been associated
with the extent ofsymptoms and clinical
findings. Spore trap sampling with micro-
scopic counting ofspores can also provide a
measure offungal mass but is laborious and
requires considerable experience (16).
WORK GROUP MEMBERS: Symptoms and
pathology. Erika von Mutius, Dorr Dearborn,
Peyton Eggleston, Suzanne Gravesen, Ragnar
Rylander. Diagnostic methods. Tuula Husman,
Robert Dales, Ruth Etzel, David Fishwick, Eckardt
Johanning. Mold exposure measurements. Kenneth
Dillon, Jeroen Douwes, Robert R. Jacobs, J. David
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